Treatment of invasive aspergillosis with nonmyeloablative allogeneic stem cell transplantation: one stone two birds.
D
D
Deeren
D000935:Antifungal Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy / Q000379:methods; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects / Q000379:methods; D055744:Invasive Pulmonary Aspergillosis / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy*; D007938:Leukemia / Q000150:complications / Q000628:therapy; D011743:Pyrimidines / Q000627:therapeutic use; D011859:Radiography; D012074:Remission Induction; D033581:Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods; D019172:Transplantation Conditioning / Q000009:adverse effects / Q000379:methods; D014184:Transplantation, Homologous / Q000009:adverse effects; D014230:Triazoles / Q000627:therapeutic use; D065819:Voriconazole
D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole